China Biologic Products Holdings
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has China Biologic Products Holdings's balance sheet done over the years? Its assets were worth $2,259,514,231 last year, which is more than in the previous period. 8% of China Biologic Products Holdings’s total assets is currently financed by debt. Its liabilities reached the amount of $177,733,991, which means an increase by 9% compared compared to last year.
Debt to Assets
| 2011 | 248892575 | 69.85M | 28.06% |
|---|---|---|---|
| 2012 | 311047150 | 53.62M | 17.24% |
| 2013 | 403781207 | 99.81M | 24.72% |
| 2014 | 446847092 | 171.58M | 38.4% |
| 2015 | 551466496 | 84.50M | 15.32% |
| 2016 | 604957509 | 83.82M | 13.86% |
| 2017 | 809057417 | 144.73M | 17.89% |
| 2018 | 2009978681 | 165.27M | 8.22% |
| 2019 | 1937858497 | 163.00M | 8.41% |
| 2020 | 2259514231 | 177.73M | 7.87% |
CBPO Balance Sheet (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 675.33M | 161.75M | 338.88M | 219.33M | 183.76M | 144.93M | 80.82M | 144.13M | 129.60M | 89.41M |
Short term investments | 517.76M | 765.50M | 613.52M | 22.89M | 0 | 38.03M | 0 | 6.60M | 0 | 0 |
Net receivables | 152.08M | 100.27M | 125.11M | 123.17M | 33.91M | 25.14M | 19.40M | 17.27M | 11.20M | 19.35M |
Inventory | 261.47M | 250.72M | 243.29M | 209.57M | 156.41M | 126.39M | 101.30M | 88.63M | 75.67M | 71.33M |
Other current assets | 28.93M | 21.46M | 36.36M | 18.13M | 19.27M | 34.60M | 78.45M | 7.64M | 5.66M | 3.59M |
Total current assets | 1.63B | 1.29B | 1.35B | 593.12M | 393.37M | 369.11M | 279.98M | 264.29M | 222.15M | 183.69M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 189.36M | 177.59M | 178.32M | 166.81M | 132.09M | 105.36M | 80.23M | 73.14M | 51.32M | 40.54M |
Goodwill | 329.86M | 308.50M | 313.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 70.12M | 72.52M | 85.46M | 24.85M | 23.38M | 23.57M | 11.90M | 10.79M | 9.36M | 12.00M |
Long term investments | 7.46M | 16.72M | 15.42M | 14.90M | 10.61M | 8.71M | 18.22M | 11.34M | 10.53M | 8.35M |
Other non-current assets | 27.11M | 62.77M | 59.98M | 9.36M | 45.48M | 44.69M | 56.49M | 44.19M | 17.66M | 4.28M |
Total non-current assets | 623.92M | 638.13M | 652.79M | 215.93M | 211.58M | 182.35M | 166.85M | 139.48M | 88.88M | 65.19M |
Total assets | 2.25B | 1.93B | 2.00B | 809.05M | 604.95M | 551.46M | 446.84M | 403.78M | 311.04M | 248.89M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 7.63M | 9.10M | 2.42M | 3.97M | 1.93M | 945.67K | 2.90M | 2.85M | 4.85M |
Short term debt | 0 | 0 | 0 | 0 | 0 | 0 | 57.90M | 9.82M | 7.93M | 11.01M |
Total current liabilities | 139.00M | 119.30M | 122.34M | 97.63M | 73.44M | 71.65M | 120.68M | 63.43M | 47.71M | 67.82M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 40M | 30M | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.68M |
Other non-current liabilities | 36.77M | 41.39M | 40.10M | 43.62M | 6.62M | 8.32M | 8.13M | 3.36M | 2.99M | 343.47K |
Total non-current liabilities | 38.72M | 43.69M | 42.92M | 47.09M | 10.37M | 12.84M | 50.90M | 36.37M | 5.90M | 2.02M |
Total liabilities | 177.73M | 163.00M | 165.27M | 144.73M | 83.82M | 84.50M | 171.58M | 99.81M | 53.62M | 69.85M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |